ERBB2 and breast carcinoma: Among all the included breast cancer cases, the incidence rate of HER-2 positive was the highest (50%, 95/190), followed by Luminal A (34.74%, 66/190) and triple-negative (7.89%, 15/190), Luminal B was the lowest (7.37%, 14/190).